scholarly article | Q13442814 |
P356 | DOI | 10.1096/FJ.10-172999 |
P698 | PubMed publication ID | 20978235 |
P50 | author | Damian J. Tyler | Q42108873 |
Jane M Francis | Q95692907 | ||
P2093 | author name string | Kieran Clarke | |
Stefan Neubauer | |||
Andrew W Johnson | |||
Caudwell Xtreme Everest Research Group | |||
Hugh E Montgomery | |||
Michael P W Grocott | |||
Andrew J Murray | |||
Denny Z H Levett | |||
Lowri E Cochlin | |||
Oliver J Rider | |||
Cameron J Holloway | |||
Ion Codreanu | |||
Naomi Hopwood | |||
P2860 | cites work | Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia | Q28586744 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hypoxia | Q105688 |
P304 | page(s) | 792-796 | |
P577 | publication date | 2010-10-26 | |
P1433 | published in | FASEB Journal | Q520194 |
P1476 | title | Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp | |
P478 | volume | 25 |
Q98513632 | A comparison of the metabolic effects of sustained strenuous activity in polar environments on men and women |
Q35781878 | Altered Oxygen Utilisation in Rat Left Ventricle and Soleus after 14 Days, but Not 2 Days, of Environmental Hypoxia |
Q35814828 | Altitude Adaptation: A Glimpse Through Various Lenses |
Q53087527 | Assessment of the Physiological Adaptations to Chronic Hypoxemia in Eisenmenger Syndrome. |
Q38876627 | Caudwell Xtreme Everest: An Overview |
Q47644344 | Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions |
Q30409643 | Design and conduct of Xtreme Everest 2: An observational cohort study of Sherpa and lowlander responses to graduated hypobaric hypoxia. |
Q26801360 | Dietary inorganic nitrate: From villain to hero in metabolic disease? |
Q34619501 | Dietary nitrate increases arginine availability and protects mitochondrial complex I and energetics in the hypoxic rat heart. |
Q92741635 | Effects of baseline heart rate at sea level on cardiac responses to high-altitude exposure |
Q30978544 | Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: data from HIGHCARE study on Mount Everest |
Q37159212 | Effects of various acute hypoxic conditions on metabolic parameters and cardiac function during exercise and recovery |
Q38575391 | Energy metabolism and the high-altitude environment. |
Q38688670 | Extreme, expedition, and wilderness medicine |
Q27316790 | Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism |
Q30369886 | Impaired myocardial function does not explain reduced left ventricular filling and stroke volume at rest or during exercise at high altitude |
Q57099804 | In silico studies on the sensitivity of myocardial PCr/ATP to changes in mitochondrial enzyme activity and oxygen concentration |
Q36176123 | Increased hemoglobin O2 affinity protects during acute hypoxia. |
Q48136688 | Increasing cardiac pyruvate dehydrogenase flux during chronic hypoxia improves acute hypoxic tolerance |
Q64273145 | Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPARα |
Q26999695 | King of the mountains: Tibetan and Sherpa physiological adaptations for life at high altitude |
Q35550645 | Left ventricular function during acute high-altitude exposure in a large group of healthy young Chinese men. |
Q38577910 | Mechanisms underlying reductions in stroke volume at rest and during exercise at high altitude. |
Q53378906 | Metabolic adaptation to chronic hypoxia in cardiac mitochondria. |
Q38512125 | Mitochondrial function at extreme high altitude |
Q35576902 | Mitochondrial responses to extreme environments: insights from metabolomics |
Q36282692 | No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure. |
Q37353795 | On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury. |
Q34751199 | Oral Coenzyme Q10 supplementation does not prevent cardiac alterations during a high altitude trek to everest base cAMP. |
Q37904019 | PET imaging of cardiac hypoxia: opportunities and challenges. |
Q90289997 | Population History and Altitude-Related Adaptation in the Sherpa |
Q97883108 | Preliminary Study of Right Ventricular Dyssynchrony Under High-Altitude Exposure: Determinants and Impacts |
Q37627314 | Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol. |
Q38262603 | Short-term adaptation and chronic cardiac remodelling to high altitude in lowlander natives and Himalayan Sherpa |
Q37480834 | The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high-energy phosphate metabolism |
Q42287080 | Tissue-specific changes in fatty acid oxidation in hypoxic heart and skeletal muscle |
Q47153207 | Total Body Water Dynamics Estimated with Bioelectrical Impedance Vector Analysis and B-Type Natriuretic Peptide After Exposure to Hypobaric Hypoxia: A Field Study |
Q30405756 | Ventricular structure, function, and mechanics at high altitude: chronic remodeling in Sherpa vs. short-term lowlander adaptation. |
Q35042804 | Xtreme Everest 2: unlocking the secrets of the Sherpa phenotype? |
Q37699678 | β-GPA treatment leads to elevated basal metabolic rate and enhanced hypoxic exercise tolerance in mice |
Search more.